Switch from tacrolimus to cyclosporine microemulsion: Immunosuppressive agents and diabetes management in liver transplant recipients in maintenance (DIALIVER).
Phase of Trial: Phase IV
Latest Information Update: 25 Apr 2017
At a glance
- Drugs Ciclosporin (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms DIALIVER
- Sponsors Novartis
- 31 Jan 2011 Actual end date (Jan 2006) added as reported by ClinicalTrials.gov.
- 31 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Dec 2005 New trial record.